Stocks · Health care · Biological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

GLUE Clue Score47

United States Fiscal year ends December CIK 0001826457 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

25 insiders · 64 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Forest Baskett

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Ali Behbahani

Director

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

+669.2%

Carmen Chang

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Anthony A. Florence Jr.

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Liza Landsman

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Mohamad Makhzoumi

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Joshua Makower

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Edward T Mathers

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

New Enterprise Associates 17, L.P. entity

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Scott D Sandell

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Peter W. Sonsini

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Paul Edward Walker

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Rick Yang

10% owner

$19.95M (1)

—

+$19.95M

7,692,298

9.02%

$81.23M

—

Cormorant Asset Management, LP entity

Former 10% Owner

$11.40M (1)

—

+$11.40M

3,202,200

3.75%

$33.82M

—

Versant Venture Capital VI, L.P. entity

10% owner

$3.00M (1)

$12.29M (7)

−$9.29M

7,750,860

9.09%

$81.85M

+225.5%

Bradley J PhD Bolzon

Director

$3.00M (1)

—

+$3.00M

8,897,053

10.43%

$93.95M

+3,041%

Filip Janku

Chief Medical Officer

—

$1.38M (6) scheduled

−$1.38M

60,612

0.0710%

$640.06K

+413.6%

Markus Warmuth

President & CEO

—

$951.14K (10)

−$951.14K

585,038

0.6858%

$6.18M

+40.5%

Edmund Dunn

Principal Accounting Officer

—

$503.36K (7) scheduled

−$503.36K

22,554

0.0264%

$238.17K

+34.6%

Sharon Townson

Chief Scientific Officer

—

$423.93K (6) scheduled

−$423.93K

67,845

0.0795%

$716.44K

—

Anthony M. Manning

Director

—

$411.20K (2) scheduled

−$411.20K

0

0.0000%

$0.00

—

Jennifer Champoux

Chief Operating Officer

—

$311.30K (6) scheduled

−$311.30K

62,371

0.0731%

$658.64K

—

Philip Nickson

Chief Business & Legal Officer

—

$151.27K (2)

−$151.27K

55,000

0.0645%

$580.80K

—

Chandra P. Leo

Director

$58.38K (1)

—

+$58.38K

10,000

0.0117%

$105.60K

—

Matthew Bowen

Principal Accounting Officer

—

$137.28 (1)

−$137.28

25,891

0.0303%

$273.41K

+19.8%